vl-2397
Small moleculeexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 20, 2018 (NCT03327727)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- FungiINHIBITOR
Fungi inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
[Al+3].CC(C)C[C@@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCN([O-])C(C)=O)NC(=O)[C@H](CCCN([O-])C(C)=O)NC(=O)[C@H](CCCN([O-])C(C)=O)NC(=O)[C@@H](CC2=CC=CC=C2)NC1=O- Mol. weight
- 914.9372 g/mol
Oral
No
Parenteral
No
Topical
No
Sources
- NCATSE39B3691TD ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03327727 | Phase 2 | Feb 20, 2018 | Vical |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Vical | For profit | 1 | 1 | 1 | 2018 |
1 organizations
Page 1 / 1